Nov 17 (Reuters) - Novartis AG:
* NOVARTIS PARAGON-HF ANALYSES SUGGEST ENTRESTO® BENEFIT BEYOND HFREF
* NOVARTIS AG SAYS GREATER BENEFIT WAS SEEN IN WOMEN WITH HFPEF AND IN HFPEF PATIENTS RECENTLY HOSPITALIZED FOR HEART FAILURE Source text for Eikon: Further company coverage: